High-dose amsacrine (AMSA) therapy of relapsed and refractory adult acute nonlymphocytic leukemia. A phase II study.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/201AF880.svg?ark=w1%2F20260515%2F201AF880)](https://nobleid.org/work/w1/20260515/201AF880)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors